Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mesoblast Limited (MESO) vs Vanguard Mega Cap Growth ETF (MGK) Price & Performance

Mesoblast LimitedTrade
Vanguard Mega Cap Growth ETFTrade

Price performance (Past 24H)

Key statistics

Mesoblast Limited vs Vanguard Mega Cap Growth ETF — how do they compare? Mesoblast Limited trades at $17.03 (market cap $2.21B), while Vanguard Mega Cap Growth ETF trades at $90.42. The key difference: Vanguard Mega Cap Growth ETF is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.

MESOMGK
Market Cap
$2.21B
Sector
TechnologyBroad Market / Factor
52-Week High
$20.96$92.06
52-Week Low
$12.88$70.70
Enterprise Value
$2.21B

Returns comparison

Trailing returns across standard periods

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO

About Vanguard Mega Cap Growth ETF

MGK is an ETF that seeks to track the performance of the CRSP US Mega Cap Growth Index. It provides a low-cost, diversified exposure to the largest growth companies in the U.S. stock market. The fund is composed of mega-cap stocks that exhibit key growth factors, including high expected long-term earnings growth, high historical sales and earnings growth, and high return on assets. MGK is typically used by investors seeking long-term capital appreciation from market-leading firms.

Read more on MGK